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Cardiorespiratory Fitness Is Inversely Associated
With Clustering of Metabolic Syndrome Risk
Factors: The Ball State Adult Fitness Program
Longitudinal Lifestyle Study
Elizabeth Kelley, MS; Mary T. Imboden, MS; Matthew P. Harber, PhD;
Holmes Finch, PhD, PStat; Leonard A. Kaminsky, PhD; and Mitchell H. Whaley, PhD
Abstract
Objective: The focus of this study was the association between the metabolic syndrome (MetSyn) and
cardiorespiratory fitness (CRF) defined as maximal oxygen uptake (VO2max). Although previous research
has shown a relationship between MetSyn and CRF, most studies are based on less objective measures of
CRF and different cardiometabolic risk factor thresholds from earlier guidelines.
Participants and Methods: The metabolic markers included in the present study were central obesity,
elevated plasma triglycerides, elevated fasting high-density lipoprotein cholesterol, impaired fasting plasma
glucose, hypertension, or pharmacologic treatment for diagnosed hypertension, hypertriglyceridemia, low
high-density lipoprotein cholesterol, or diabetes. A cohort of 3636 adults (1629 women, 2007 men; mean 
SD age, 44.712.3 years) completed CRF and metabolic risk factor assessment between January 1, 1971,
and November 1, 2016. The CRF was defined as a measured VO2max from a cardiopulmonary exercise test
on a treadmill, with a respiratory exchange ratio value of 1.0 or more.
Results: Prevalence of MetSyn (3 factors) was 26% (n¼953) in the cohort, with men having a greater
likelihood for MetSyn compared with women (P<.001). The difference in VO2max between those
individuals with MetSyn and those without was approximately 2.3 (2.0-2.5) metabolic equivalents.
Logistic regression analyses showed a significant inverse and graded association between quartiles of CRF
and MetSyn for the group overall (P<.001), with odds ratios (95% CI) using the lowest fitness group as
the referent group of 0.67 (0.55-0.81), 0.41 (0.34-0.51), and 0.10 (0.07-0.14) for VO2max (P<.001). The
sex-specific odds ratios were 0.25 (0.18-0.34), 0.05 (0.02-0.10), and 0.02 (0.01-0.09) for women and
0.43 (0.31-0.59), 0.19 (0.14-0.27), and 0.03 (0.02-0.05) for men (P<.001).
Conclusion: These results with current risk factor thresholds and a large number of women demonstrate
that low VO2max is associated with MetSyn.
ª 2018 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/) n Mayo Clin Proc Inn Qual Out 2018;2(2):155-164
T he metabolic syndrome (MetSyn) is ahigh-risk phenotype characterized bythe combination of cardiometabolic
risk factors, including obesity, dyslipidemia,
hypertension, impaired fasting glucose, proin-
flammatory state, and a prothrombotic state.1
First described by Reaven,2 MetSyn is believed
to be a common physiologic predecessor for
chronic diseases including cardiovascular dis-
ease,3-5 type 2 diabetes mellitus,6 and prema-
ture mortality.4,7 Defining criteria for MetSyn
have been established by multiple agencies
over time,1,8-11 but the most frequently used
are those published by the National Choles-
terol Education Program (NCEP)/Adult Treat-
ment Panel12 and the International Diabetes
Foundation.9,11 The prevalence of MetSyn
has varied as a function of the defining
criteria,13 but it has been reported to exist in
one-fourth to one-third of adults in the United
States.13-16 Moreover, the prevalence appears
to be on the rise,14-16 particularly in
women,14-16 and with advancing age, with
the greatest prevalence seen in adults 60 years
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or older.14 When combining the adverse con-
sequences associated with MetSyn with its
continuing rise in prevalence, it seems clear
that MetSyn will continue to represent a
serious public health issue well into the future.
Low cardiorespiratory fitness (CRF) has
been associated with the presence of metabolic
risk factor clustering and MetSyn in numerous
published studies.17-31 However, the defining
criteria for MetSyn, the assessment of CRF, and
the specific cohort characteristics have varied
considerably among these studies. Variations in
any one or all the above parameters could
influence the overall study findings and the
generalizability of the results. Early reports
used higher thresholds for impaired fasting
blood glucose (110 mg/dL [to convert to
mmol/L, multiply by 0.0555]),18,21,23,26-28,31
hypertension (blood pressure 140/90 mm
Hg),18,27,31 and/or varying measures/thresholds
for abdominal obesity,17,18,27,31 which were
more consistent with the defining criteria for
MetSyn at the time. Other studies used popula-
tion- and/or country-specific definitions for
abdominal obesity.17,24,28,30 Only 3 recent re-
ports incorporated the current MetSyn risk fac-
tor criteria for each of the 5 common
markersdincluding drug treatment for hyper-
tension, dyslipidemia, and/or elevated fasting
glucose as a qualifying factor.25,29,30 Of these, 2
of the studies included only older30 or only
younger29 adults, and only 1 study included
women.30
In light of the recent public health recom-
mendation to include assessment of CRF in
medical examinations32 and the advocacy
for inclusion of cardiopulmonary exercise
testing (CPX),33,34 more information from
studies in which CRF was directly measured
may aid clinicians in the evaluation and
treatment of multiple chronic diseases (eg,
cardiovascular disease and heart failure). Most
of the published studies on MetSyn incorpo-
rated a CRF level estimated from a maximal
exercise test,17,19,21-23,26-31 which has been
associated with an estimation error of between
1 and 2 metabolic equivalents. Only 5 of
the published studies on MetSyn used
CPX-derived maximal oxygen uptake
(VO2max)
23,27-30 to define CRF. Two of these
studies used leg cycling as the mode of exercise,
which is associated with 10% to 20% lower
measured oxygen uptake as compared with
treadmill testing.23,27,35 Four of the 5 studies
incorporated solely older23,30 or younger28,29
adults, which would not be as generalizable
across a wide age spectrum. Furthermore,
only 2 of the studies in which CRF was defined
using measured VO2max included women, and
these 2 cohorts collectively represented approx-
imately 1171 older women.23,30 When
combining the limited number of participants
within these studies with the sex and/or age
delimitations, the VO2max thresholds associated
with increased risk for MetSyn in middle-aged
adults are less clear. Therefore, additional
information from studies that include (1)
contemporary risk factor thresholds, (2) a large
sample and broad age range of men and
women, and (3) VO2max determined with
CPX is needed to refine the understanding of
the association between CRF and MetSyn.
The purpose of the present investigation
was to assess the association between directly
measured CRF (VO2max) and metabolic risk
factor clustering in a broad age range of men
and women using current MetSyn risk factor
criteria.
PARTICIPANTS AND METHODS
Study Population and Design
Participants completed laboratory assessments
through the Ball State Adult Fitness Program
Longitudinal Lifestyle STudy (BALL ST), which
is an ongoing population-based program initi-
ated in 1970 to promote healthy lifestyles and
physical fitness. This retrospective cross-
sectional analysis included 3636 self-referred
adult males and females (aged 19-95 years)
who completed a physical examination
including maximal exercise testing with
respiratory gas analysis (CPX) within the
BALL ST between the years January 1, 1971,
and November 1, 2016. Deidentified data
were exported from the BALL ST longitudinal
database. Inclusion criteria consisted of being
18 years or older, having complete data for all
MetSyn risk markers (see below), and attain-
ment of greater than or equal to 1.0
respiratory exchange ratio during the maximal
exercise test. For individuals with multiple
test records, the first test with complete data
for all relevant MetSyn risk markers was used.
All data were deidentified, and participants pro-
vided written informed consent for their
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information to be used for research. Ball State
University (BSU) Institutional Review Board
approved all data collection procedures and
determined the study “exempt” because of the
use of deidentified data.
Clinical Measurements
All participants were instructed to refrain from
exercise, caffeine, and alcohol for 12 hours
before testing and arrive on the initial day of
testing in a fasting state. They were also
instructed to continue their regular medication
routines. Participants completed a health history
questionnaire, which provided self-reported
information about medical history, lifestyle
habits (eg, smoking, physical activity, and
diet), and medications.36 Each participant then
completed a series of assessments including
anthropometric measurements (height, weight,
andwaist andhip circumferences), body compo-
sition, resting heart rate and blood pressure,
blood chemistry, and resting 12-lead electrocar-
diography. Standardized laboratory techniques
were used for all resting assessments and have
been described in detail elsewhere.36-38
Metabolic Markers
Metabolic syndrome markers and their thresh-
olds were defined according to the NCEP.1,8
Markers and thresholds included central
obesity (waist circumference 102 cm for
men or 88 cm for women), elevated fasting
plasma triglycerides (150 mg/dL; to convert
to mmol/L, multiply by 0.0113), low high-
density lipoprotein cholesterol (HDL-C; <40
mg/dL for men or <50 mg/dL for women; to
convert to mmol/L, multiply by 0.0259),
elevated fasting plasma glucose (100 mg/dL),
hypertension (blood pressure 130 mm Hg
systolic or 85 mm Hg diastolic), or pharmaco-
logic treatment for diagnosed hypertension,
hypertriglyceridemia, low HDL-C, or diabetes.
Waist girth was taken in the horizontal plane
at the smallest circumference in the abdominal
region, generally 2 to 4 in above the umbili-
cus. Plasma lipids were measured after a 12-
hour fast, and resting blood pressure values
were measured in the seated position after a
5-minute rest period. A minimum of 2 blood
pressure measurements were recorded, with
additional measurement taken if the initial 2
differed by more than 6/4 mm Hg for systolic
TABLE 1. Defining Characteristics of the BALL ST Cohorta,b,c
Characteristic Men (n¼2007) Women (n¼1629) Total (n¼3636)
Age (y)d 45.011.9 44.212.7 44.712.3
Current smoking (%)d 13.9 8.8 11.6
BMI (kg/m2)d 27.75.0 27.06.3 27.45.6
Waist circumference (cm)d 96.113.3 82.814.4 90.115.3
Resting SBP (mm Hg)d 12615 11815 12215
Resting DBP (mm Hg)d 8110 7510 7910
Total cholesterol (mg/dL)d 208.445.5 200.440.6 204.843.4
LDL-C (mg/dL)d 130.737.9 118.335.2 124.937.2
HDL-C (mg/dL)d 45.712.4 58.015.2 51.415.1
Triglycerides (mg/dL)d 146.8120.6 116.373.0 134.8103.2
Fasting glucose (mg/dL) 98.622.9 93.819.0 96.521.4
Physically active (%)d 32.5 23.1 28.2
Resting HR (beats/min)d 6711.5 7010.0 6811.0
Maximal HR (beats/min) 17617.6 17516.4 17517.0
VO2max (mL/kg/min)
d 36.210.3 27.58.0 32.210.3
FRIEND percentiled 4427.0 4826.0 4527.0
aBMI ¼ body mass index; BALL ST¼ Ball State Adult Fitness Longitudinal Lifestyle Study; DBP ¼ diastolic blood pressure; FRIEND ¼
Fitness Registry and the Importance of Exercise National Database; HDL-C ¼ high-density lipoprotein cholesterol; HR ¼ heart rate;
LDL-C ¼ low-density lipoprotein cholesterol; SBP ¼ systolic blood pressure; VO2max ¼ maximal oxygen uptake.
bValues presented as mean  SD unless otherwise specified. Current cigarette smoking and habitual physical activity as described within
Whaley et al.36 FRIEND percentile referenced from Kaminsky et al.34
cSI conversion units: To convert total cholesterol, LDL-C, and HDL-C values to mmol/L, multiply by 0.0259; to convert triglyceride values
to mmol/L, multiply by 0.0113; to convert glucose values to mmol/L, multiply by 0.0555
dSignificant difference between males and females (P<.001).
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or diastolic, respectively. Participants report-
ing medication use for treatment of hypertri-
glyceridemia or low HDL-C were classified as
positive for these metabolic markers.8,11 The
presence of the metabolic syndrome was
defined as meeting the criteria for 3 or more
of the metabolic markers.8
Exercise Testing and CRF
All participants completed a maximal CPX on a
treadmill as part of their physical examination.
Exercise test protocols varied and included
Bruce,39 Ball State University Bruce Ramp,40
modified Balke,41 or other nonspecified proto-
cols. In most cases, selection of test protocol
was individualized on the basis of participant
characteristics, with a goal to achieve maximal
effort within 8 to 12 minutes. Exercise heart
rate was measured using electrocardiography
(single-lead or 12-lead, depending on date)
and recorded each minute at peak exercise
and during recovery from the exercise test. Ex-
ercise blood pressures were monitored
manually during exercise and recovery. Gas ex-
change data were collected using open circuit
spirometry with methods described previ-
ously.36 Standardized procedures for metabolic
cart calibration were followed for all tests, and
tests were supervised by clinical exercise phys-
iologists, with additional medical supervision
when appropriate.42 Participants were verbally
encouraged to exercise to volitional fatigue.
Cardiorespiratory fitness was indicated by
VO2max, defined as the average of 2 or 3 consec-
utive VO2 values within 2 mL per kg/minute,
occurring in the last 2 minutes of the CPX.
Statistical Analyses
Descriptive statistics were computed for all
study variables and are presented in Table 1.
For analyses purposes, cigarette smoking was
characterized as current smoker, former
smoker, or never smoked, and physical activ-
ity was characterized as regularly active in
endurance exercise (3 sessions per week of
running, walking, swimming, and/or cycling)
or not. Differences in participant characteris-
tics and metabolic markers between those
with and without the MetSyn were tested for
statistical significance with Student t test or
the c2 test where indicated.
Several methods were used to assess the
association between CRF and MetSyn. First,
CRF was used as a continuous scale variable
in analyses (mL/kg per minute) and the age-
and sex-adjusted difference in CRF was
computed between those with and without
MetSyn. Second, sex-stratified CRF quartiles
were created and logistic regression models
were computed using the lowest fitness quar-
tile as the reference group. Finally, as a com-
plementary approach to assessing the
relationship between CRF and MetSyn, an in-
dividual’s VO2max was converted to an age-
and sex-specific percentile score using the
reference values from the Fitness Registry
and the Importance of Exercise National Data-
base (FRIEND).34 For analysis, participants
were stratified into lowest VO2max (Q1
25th percentile), Q2 was 26th to 50th
percentile, Q3 was 51st to 75th percentile,
and highest VO2max (Q4 >75th percentile)
of the FRIEND. Odds ratios were computed
for the FRIEND quartiles using the lowest
fitness category (Q1) as the reference group.
TABLE 2. Prevalence of Metabolic Syndrome Risk Factorsa
Risk factor
Men
(n¼2007)
Women
(n¼1629)
Combined
(N¼3636)
Waist circumferenceb 28.1% (564) 31.7% (516) 29.7% (1080)
Impaired fasting glucosec 37.2% (746) 23.6% (385) 36.1% (1311)
Hypertensiond 52.3% (1049) 32.9% (536) 43.6% (1585)
HDL-Ce 29.2% (586) 28.5% (464) 28.9% (1050)
Triglyceridesf 34.2% (686) 21.2% (345) 28.4% (1031)
aHDL-C ¼ high-density lipoprotein cholesterol.
b102 cm for men; 88 cm for women.
c100 mg/dL (to convert to mmol/L, multiply by 0.0555) or drug treatment for impaired fasting
glucose.
d130 systolic or 85 diastolic mm Hg; or drug treatment for hypertension.
e<40 mg/dL for men; <50 mg/dL for women, (to convert to mmol/L, multiply by 0.0259), or drug
treatment for low HDL-C.
f150 mg/dL (to convert to mmol/L, multiply by 0.0113) or drug treatment for high serum
triglycerides.
TABLE 3. Clustering of Metabolic Syndrome Risk Factors
No. of risk
factors meeting threshold
Men
(n¼2007)
Women
(n¼1629)
Combined
(N¼3636)
0 20.0% (403) 32.9% (537) 25.9% (940)
1 26.4% (529) 29.0% (479) 27.7% (1008)
2 23.3% (467) 16.5% (268) 20.2% (735)
3a 17.0% (341) 12.0% (195) 14.7% (536)
4a 9.5% (190) 6.4% (104) 8.1% (294)
5a 3.8% (77) 2.8% (46) 3.4% (123)
aThose with 3 of the risk factors were coded for analyses as having the metabolic syndrome.
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All analyses were performed using SPSS
version 24 and SAS version 9.3. A P value of
less than .01 was considered statistically
significant.
RESULTS
The prevalence of each of the metabolic markers
of the MetSyn is presented in Table 2. Hyperten-
sion was the most frequent risk factor, followed
by impaired fasting blood glucose, and then the
others. The proportion of the cohort with clus-
tering of one or more metabolic markers is pre-
sented in Table 3. Within this cohort, the
presence of MetSyn as defined by having 3 or
more risk factors was 26% (953 of 3636). Men
were more likely to have each of the associated
risk factors and MetSyn than women (30% vs
21%) (P<.001). Those with MetSyn were also
older, less physically active, and had lower
maximal heart rate and VO2max compared with
those who were free of the syndrome
(P<.001). Those within the cohort who had
MetSyn had a VO2max value of 7.8 (7.1-8.5)
mL/kg per minute lower than did those without
MetSyn. After adjusting for age and sex in the
model, those with MetSyn had a CRF value of
7.2 (6.6-7.7) mL/kg per minute lower than did
those without MetSyn (Table 4).
Results from the logistic regression based
on the cohort analyses are presented in
TABLE 4. Defining CharacteristicsdMetSyn Compared With Apparently Healthy Individualsa,b,c
Characteristic MetSyn (n¼953) No MetSyn (n¼2683)
Age (y)d 48.311.8 43.412.2
Current smoking (%) 11.5 11.6
BMI (kg/m2)d 32.35.0 25.66.3
Waist circumference (cm)d 104.513.6 85.012.3
Resting SBP (mm Hg)d 13216 11914
Resting DBP (mm Hg)d 8510 7710
Total cholesterol (mg/dL)d 213.248.4 201.941.1
LDL-C (mg/dL)d 129.738.2 123.236.7
HDL-C (mg/dL)d 45.712.4 58.015.2
Triglycerides (mg/dL)d 146.8120.6 116.373.0
Fasting blood glucose (mg/dL)d 110.031.6 91.713.3
Physically active (%)d 15.2 33.2
Resting HR (beats/min)d 7210.6 6710.8
Maximal HR (beats/min)d 16919.2 17815.6
VO2max (mL/kg/min)
d 26.67.1 34.310.5
FRIEND percentiled 2820.0 5226.0
aBMI ¼ body mass index; DBP ¼ diastolic blood pressure; FRIEND ¼ Fitness Registry and the Importance of Exercise National Database;
HDL-C ¼ high-density lipoprotein cholesterol; HR ¼ heart rate; LDL-C ¼ low-density lipoprotein cholesterol; MetSyn ¼ metabolic
syndrome; SBP ¼ systolic blood pressure; VO2max ¼ maximal oxygen uptake.
bValues presented as mean  SD unless otherwise specified. FRIEND percentile referenced from Kaminsky et al.34
cSI conversion units: To convert total cholesterol, LDL-C, and HDL-C values to mmol/L, multiply by 0.0259; to convert triglyceride values
to mmol/L, multiply by 0.0113; to convert glucose values to mmol/L, multiply by 0.0555
dSignificant difference between MetSyn and healthy (P<.001).
TABLE 5. Prevalence and Cohort Logistic Regression Models for MetSyna,b
Model Lowest-fit quartile Quartile 2 Quartile 3 Highest-fit quartile
N¼MetSyn 484 (53.3%) 294 (32.4%) 148 (16.3%) 27 (3.0%)
OR 1.0 0.67 (0.55-0.81) 0.41 (0.34-0.51) 0.10 (0.07-0.14)
ORc 1.0 0.49 (0.40-0.60) 0.30 (0.34-0.38) 0.07 (0.05-0.10)
ORd 1.0 0.29 (0.23-0.37) 0.13 (0.10-0.17) 0.03 (0.02-0.04)
aMetSyn ¼ metabolic syndrome; OR ¼ odds ratio.
bData for ORs are presented as ORs (CIs).
cAdjusted for age at test date.
dAdjusted for age at test date, sex, physical activity, and cigarette smoking.
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Tables 5 and 6. They show a statistically signif-
icant inverse and graded association between
VO2max and the prevalence of MetSyn for the
group overall (P<.001) and for the men and
women separately (P<.001). In the analysis
that included all participants (n¼3636), the
association was statistically significant after
adjusting for age and sex (P<.001), and the
prevalence of MetSyn ranged from 53.3% in
the lowest-fit quartile (Q1) to 3.0% in the
most-fit quartile (Q4). The most-fit quartile
was more than 20 times less likely to have
MetSyn compared with their least-fit counter-
parts, and the association showed a graded
response, with the middle 2 quartiles also
significantly less likely to have the MetSyn
than the least-fit quartile (P<.01). This rela-
tionship was also shown for men and women,
respectively.
Those with MetSyn had a VO2max percentile
from the FRIEND of 2820 percentile as
opposed to those without the syndrome who
averaged a VO2max percentile of 5226
(P<.001). The logistic regression results for
the analysis that incorporated the FRIEND
version of CRF for the women and men are pre-
sented in Table 7 and also show a significant in-
verse gradient for MetSyn and VO2max (P<.01).
The results remain significant after adjusting for
age in the logistic regression models.
DISCUSSION
The major finding of this study was the signifi-
cant inverse association between VO2max and
MetSyn, with the most physically fit individuals
(upper quartile) being more than 20 times less
likely to have MetSyn compared with the
least-fit individuals. The difference in VO2max
between those individuals with MetSyn and
those without was approximately 2.5 metabolic
equivalents. The association between VO2max
and MetSyn was also graded across the range
of fitness scores within our cohort, with the 2
middle groups having intermediate prevalence
rates (Tables 5 and 6). This relationship
remained significant and was strengthened by
adjusting for age and sex in the models. This
large cohort of men and women had a broad
range of scores for age, VO2max, and the risk fac-
tors for MetSyn.
TABLE 6. Prevalence and Sex-Specific Cohort Logistic Regression Models for MetSyna,b
Model Lowest-it quartile Quartile 2 Quartile 3 Highest-fit quartile
Women
N¼MetSyn 192 (47.2%) 97 (23.8%) 53 (13.0%) 3 (0.7%)
VO2max (mL/kg/min) 21.5 21.6-26.1 26.2-31.7 31.8
OR 1.0 0.25 (0.18-0.34) 0.05 (0.02-0.10) 0.02 (0.01-0.09)
ORc 1.0 0.26 (0.19-0.36) 0.05 (0.03-0.12) 0.03 (0.01-0.13)
Men
N¼MetSyn 292 (58.3%) 197 (39.2%) 95 (18.9%) 24 (4.8%)
VO2max (mL/kg/min) 28.7 28.8-35.1 35.2-42.6 42.7
OR 1.0 0.43 (0.31-0.59) 0.19 (0.14-0.27) 0.03 (0.02-0.05)
ORc 1.0 0.39 (0.27-0.55) 0.16 (0.11-0.24) 0.03 (0.02-0.05)
aMetSyn ¼ metabolic syndrome; OR ¼ odds ratio; VO2max ¼ maximal oxygen uptake.
bData for ORs are presented as ORs (CIs).
cAdjusted for age at test date, physical activity, and cigarette smoking status.
TABLE 7. Prevalence and Logistic Regression Models for MetSyn Using the FRIEND Percentilesa,b
Model
Lowest-fit FRIEND
25th percentile
Quartile 2
26th-50th percentile
Quartile 3
51st-75th percentile
Highest-fit FRIEND
76th percentile
Women with MetSyn 179 (43.2%) 95 (20.6%) 53 (12.6%) 18 (5.4%)
Odds ratio 1.0 0.36 (0.26-0.49) 0.19 (0.13-0.30) 0.07 (0.04-0.13)
Men with MetSyn 357 (54.6%) 169 (29.4%) 64 (14.4%) 18 (5.4%)
Odds ratio 1.0 0.31 (0.24-0.40) 0.13 (0.09-0.18) 0.06 (0.04-0.09)
aFRIEND ¼ Fitness Registry and the Importance of Exercise National Database; MetSyn ¼ metabolic syndrome.
bFRIEND percentile referenced from Kaminsky et al.34
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Although these findings are generally consis-
tent with previous studies,17-21,23,25-31 our
results are based on current risk factor thresholds
for MetSyn,1,8 represent the largest cohort with
directly measured VO2max of the available
studies, and incorporate the FRIEND percentiles
into our analysis.34 Our results demonstrate that
a lower VO2max (or lower VO2max percentile
from FRIEND) is associated with a greater prev-
alence of MetSyn in both men and women, and
based on the analyses deployed, our results are
graded in nature.
Only a handful of studies of CRF and
MetSyn20,25,29 have used the current risk factor
thresholds defined by the NCEP/Adult Treat-
ment Panel,1,8 which is most likely due to the
modifications in the risk factor thresholds
over time. Nonetheless, these modifications in-
crease the number of individuals classified as
having MetSyn. Considering only those studies
that used the current risk factor thresholds,
Ekblom et al20 studied approximately 686
men and women and quantified CRF using a
submaximal cycling test. They did not measure
VO2max in their study, but using the current
thresholds did report that the sex-adjusted
high-fit group was less likely to have MetSyn.
Misigoj-Durakovic et al29 studied 577 younger
men (mean age, 30 years) and used a maximal
treadmill test with measured VO2max. These au-
thors reported higher odds ratios for the upper
3 CRF quartiles (0.42, 0.38, and 0.10) when
using the least-fit quartile as the reference
group compared with the present study (0.37,
0.16, and 0.02 for men). Their study was in
younger men, so direct comparisons of results
are not prudent, but our findings suggest a
stronger graded relationship in men and add
women to these findings. Finally, Ingle et al25
studied a much larger sample of men
(w9666) compared with the present study
but used a submaximal treadmill test to assess
CRF and reported only 2 categories of men, un-
fit vs fit. Although their higher fit men were less
likely to have clustering of the risk factors, their
odds ratio of 0.51 for the fit men is not directly
comparable to that in the present study. Our
results, using the criterion standard (eg,
measured VO2max), represent a stronger study
design compared with these reports.
Our study results are novel for the inclu-
sion of measured VO2max as the measure
of CRF in a cohort of men and women with
a broad age range. Most published
studies17,19,21-23,26-31 incorporated a maximal
exercise test for assessment of CRF, but of
these, only 5 used directly measured VO2max
as the measure of CRF.23,27-30 Lakka et al27
and Hassinen et al23 reported results where
VO2max was quantified using a cycle ergometer
test, whereas Lee et al,28 Misigoj-Durakovic
et al,29 and Sandbakk et al30 deployed a
maximal treadmill test. Although all the
studies reported a significant inverse associa-
tion between VO2max and the prevalence of
MetSyn, the studies most comparable to the
present one are those measuring VO2max using
a motorized treadmill protocol. Lee et al28
assessed 909 young men (age, 242 years)
who had a much higher CRF, and the risk fac-
tor thresholds for waist circumference and
fasting blood glucose were not the same as
in the present study. Nonetheless, they
reported that the middle and high fitness ter-
tiles had a significantly lower risk for MetSyn.
Sandbakk et al30 studied older men and
women (aged 70-77 years) and reported that
high CRF was associated with a lower risk
for MetSyn. However, their risk thresholds
for waist girth were lower than in the present
study and the present study included a much
wider range of age and CRF. Finally, Misigoj-
Durakovic et al29 assessed a smaller group of
younger men (577; age, 19-47 years) and as
stated above, their results for the highest
fitness group of men were similar to those of
the present study. Based on these available
studies that defined CRF measured with CPX
and treadmill exercise, our results represent
the association with a much broader age range
of both men and women.
Although multiple studies included
women19-24,30,31 and show the inverse associ-
ation between a measure of CRF and MetSyn,
the present study represents the largest group
of women that used a measured VO2max to
define CRF. Four of the studies that included
women were from the same cohort19,21,22,31
and defined CRF with a maximal exercise
test without CPX. Although they reported an
inverse association between CRF and MetSyn
for women, they reported much lower overall
prevalence rates for MetSyn compared with
the present study (6.5% and 4.2% vs 21%).
Differences in prevalence rates are partly due
to a difference in the risk factor thresholds
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used compared with the present study (fasting
blood glucose, 110 mg/dL vs 100 mg/dL),
but could also be due to other factors such as
sampling differences. The number of women
with each metabolic risk factor was signifi-
cantly lower in the study by Farrell et al21
compared with the present study, and the
other study is from the same cohort.
There are 2 studies that incorporated
VO2max as the measure of CRF in women.
23,30
Although these studies used slightly different
risk factor thresholds and represented much
older women (Sandbakk et al30: age, 70-77
years; Hassinen et al23: age, 655 years), they
do represent studies with a measured VO2max.
Both these studies used tertiles of VO2max in
their analyses, and the lowest-fit women were
significantly more likely to have MetSyn
compared with the highest-fit women in their
respective analyses. The present study repre-
sents a significantly larger sample of women
and also represents a much wider age range
compared with these previous studies that
defined CRF with VO2max. Therefore, our
results extend the findings of these previous re-
ports to a much broader age range of women.
This is the first study to incorporate the
FRIEND database values for CRF into ana-
lyses34 (Table 7). Each participant in the pre-
sent study had their VO2max converted into a
sex- and age-adjusted FRIEND percentile, and
then this value was used in the logistic regres-
sion model as opposed to their actual VO2max
value. Bothmen andwomen showed significant
drops in MetSyn across the CRF continuum.
The largest declines were from the lowest-fit
groups for men and women (25th percentile)
to the adjacent category (Q2), but the relation-
ship was graded, meaning that moving fromQ2
to Q3 and ultimately to the highest-fit group
represented a statistically significant decline in
risk for MetSyn within our study. These results
support our original findings by incorporating a
national CRF database into the analytic model.
The FRIEND for CRF accounts for the naturally
occurring differences in VO2max that occur
between sexes and across the age continuum
and provides a national database for compari-
son across studies.
The protective effects of higher VO2max
that are shown in the present study represent
values that are attainable by most of the gen-
eral public. Cardiorespiratory fitness values
of approximately 22.0 and 29.0 mL/kg per
minute for women and men, respectively,
which represents the threshold between the
lowest VO2max quartile and the second quar-
tile, are reasonably attainable through regular
aerobic exercise training. Further reduction
in MetSyn was seen in those individuals who
were in the 2 upper fitness quartiles. Age did
not affect the logistic results for the women
in a meaningful way and only modestly
affected the results for men. Additional sup-
port for the modest effect of age on our results
comes from the FRIEND, which categorizes
VO2max into sex-age categories. Values for
measured VO2max below the 25th percentile
(sex- and age-adjusted) in the FRIEND are
clearly risky for the presence of MetSyn.
Therefore, we suspect that the differences in
fitness associated with aging did not impact
our results much. Obviously, multiple factors
are related to our measure of CRF, but seden-
tary lifestyle is a major part of the relationship.
Most of the adults in the present analysis were
sedentary at the time of exercise testing.
Further protection from MetSyn would likely
be accrued as one moves up the CRF contin-
uum with regular exercise training.
There are several strengths and limitations
to the present study. Strengths include a large
apparently healthy cohort that was self-
referred, measured VO2max, and inclusion of
the FRIEND in the analysis. To our knowledge,
this study represents the largest cohort of adults
that has shown this association with MetSyn
using VO2max as the measure of CRF. Limita-
tions include that the cohort was approximately
95% percent white and that exercise testing
and risk factor assessments took place over a
large period of years with only slight modifica-
tions in some testing procedures. However, we
believe these limitations to be marginal because
the laboratory techniques used were similar
and consistent with guidelines at the time of
testing. What did change over time are the
metabolic risk factor values that were consid-
ered abnormal, and we have used the most
recent thresholds for each risk factor in our an-
alyses. In addition, because there was a rela-
tively low prevalence of MetSyn in the highest
CRF groups for men and women, caution is
warranted in the interpretation of the risk level
for these groups. And finally, results from the
present study are cross-sectional in nature, so
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we should be cautious in drawing conclusions
about causation.
CONCLUSION
The present study confirms the association be-
tween CRF and MetSyn in men and women
and extends it to include CRF as defined by
measured VO2max. The results of the present
study are also strengthened by the FRIEND
application, which standardizes VO2max across
sex and gender percentiles and are generaliz-
able to the larger population. On the basis of
our results, clinicians should first focus on
the lowest-fit individuals and encourage
them to adopt a more physically active life-
style, which would improve their VO2max.
Because our results were graded in nature, in-
dividuals should be encouraged to adopt a
regular exercise program that contributes to
an improvement in VO2max to upper quartiles.
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cholesterol; MetSyn = metabolic syndrome; NCEP = Na-
tional Cholesterol Education Program; VO2max = maximal
oxygen uptake
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